Importance Barrett esophagus containing low-grade dysplasia is associated with an
increased risk of developing esophageal adenocarcinoma, a cancer with a rapidly …

Background and Aims A prior randomized study (Surveillance versus Radiofrequency
Ablation study [SURF study]) demonstrated that radiofrequency ablation (RFA) of Barrett's …

Background & Aims Barrett's esophagus (BE) with low-grade dysplasia (LGD) can progress
to high-grade dysplasia (HGD) and esophageal adenocarcinoma (EAC). Radiofrequency …

Background Barrett's esophagus, a condition of intestinal metaplasia of the esophagus, is
associated with an increased risk of esophageal adenocarcinoma. We assessed whether …

BACKGROUND & AIMS: Radiofrequency ablation (RFA) can eradicate dysplasia and
intestinal metaplasia in patients with dysplastic Barrett's esophagus (BE), and reduce rates …

Objectives: Barrett's esophagus (BE) is the only identifiable premalignant condition for
esophageal adenocarcinoma (EAC). Management of BE with low-grade dysplasia continues …

BACKGROUND & AIMS: The goal of radiofrequency ablation (RFA) for patients with Barrett's
esophagus (BE) is to eliminate dysplasia and metaplasia. The efficacy and safety of RFA for …

OBJECTIVES: Radiofrequency ablation (RFA) of Barrett's esophagus (BE) is safe and
effective in eradicating dysplasia and intestinal metaplasia, and may reduce rates of …

Background & Aims After radiofrequency ablation (RFA), patients may experience
recurrence of Barrett's esophagus (BE) after complete eradication of intestinal metaplasia …

Background With recent advances in endoscopy, endoscopic techniques have surpassed
esophagectomy in the treatment of dysplastic Barrett's esophagus (BE). Objective To …